| Literature DB >> 25861242 |
Naomi Ono1, Junko Nakahira1, Toshiyuki Sawai1, Yosuke Kuzukawa1, Toshiaki Minami1.
Abstract
BACKGROUND: Abdominal aortic replacement requires an extensive incision and strict blood pressure control, making rapid extubation of the tracheal tube and pain management difficult. The effects of extubation timing on the postoperative course and medical costs in the intensive care unit (ICU) were analyzed.Entities:
Keywords: Abdominal aortic replacement surgery; Cost in intensive care unit; Timing of extubation
Mesh:
Year: 2015 PMID: 25861242 PMCID: PMC4390093 DOI: 10.1186/s12871-015-0027-7
Source DB: PubMed Journal: BMC Anesthesiol ISSN: 1471-2253 Impact factor: 2.217
Baseline demographic and clinical characteristics of patients who underwent abdominal aortic replacement surgery and were extubated on the day of surgery (Group A) or on subsequent days (Group B)
| Group A (n = 95) | Group B (n = 96) | ||
|---|---|---|---|
| Age (years) | 69±9 | 73±7 | 0.004 |
| Height (cm) | 164.4±7.8 | 164.5±7.7 | 0.939 |
| Weight (kg) | 60.3±8.8 | 62.9±12.5 | 0.166 |
| Female | 11 (11.6%) | 12 (12.5%) | 0.845 |
| Medical history | |||
| Hypertension | 63 (66.3%) | 73 (76.0%) | 0.138 |
| Diabetes mellitus | 20 (21.1%) | 23 (24.0%) | 0.631 |
| Hyperlipidemia | 21 (22.1%) | 26 (27.1%) | 0.425 |
| Chronic obstructive pulmonary disease | 7 (7.4%) | 4 (4.2%) | 0.372 |
| Interstitial pneumonia | 1 (1.1%) | 2 (2.1%) | 1.000 |
| Asthma | 4 (4.2%) | 1 (1.0%) | 0.211 |
| Angina pectoris | 9 (9.5%) | 16 (16.7%) | 0.141 |
| Previous cardiac surgery | 14 (14.7%) | 16 (16.7%) | 0.714 |
| Coronary intervention | 15 (15.8%) | 28 (29.2%) | 0.027 |
| Arrhythmia | 6 (6.3%) | 7 (7.3%) | 0.789 |
| Cardiac disease | 2 (2.1%) | 3 (3.1%) | 1.000 |
| Hemodialysis | 2 (2.1%) | 1 (1.0%) | 0.621 |
| Medication | |||
| Calcium channel blocking agent | 45 (47.4%) | 56 (58.3%) | 0.129 |
| β receptor blocker | 17 (17.9%) | 18 (18.8%) | 0.879 |
| ARB/ACEI | 43 (45.3%) | 48 (50.0%) | 0.512 |
| Statin | 20 (21.1%) | 21 (21.9%) | 0.890 |
Data are expressed as mean ± standard deviation or as number (%).
Abbreviations:ARB angiotensin II receptor blocker; ACEI angiotensin-converting enzyme inhibitor.
Postoperative outcomes in patients who underwent abdominal aortic replacement surgery and were extubated on the day of surgery (Group A) or on subsequent days (Group B)
| Group A (n = 95) | Group B (n = 96) | ||
|---|---|---|---|
| Operating time (min) | 271 ± 60 | 313 ± 85 | 0.001 |
| Anesthetic time (min) | 378 ± 61 | 424 ± 85 | < 0.001 |
| Intraoperative parameters | |||
| Infusion volume (ml) | 4169 ± 1125 | 4908 ± 1507 | < 0.001 |
| Transfusion | 38 (40.0%) | 48 (50.0%) | 0.165 |
| Urinary volume (ml) | 729 ± 559 | 741 ± 551 | 0.923 |
| Amount of bleeding (ml) | 711 ± 459 | 900 ± 641 | 0.017 |
| Mesenteric traction syndrome | 7 (7.4%) | 14 (14.6%) | 0.111 |
| Final ACT | 147 ± 18 | 152 ± 24 | 0.280 |
| Epidural anesthesia | 33 (34.7%) | 12 (12.5%) | < 0.001 |
| ICU-related parameters | |||
| Albumin volume | 177 ± 379 | 338 ± 427 | < 0.001 |
| Transfusion | 5 (5.3%) | 12 (12.5%) | 0.079 |
| Postoperative complications | |||
| Respiratory disorders | 2 (2.1%) | 8 (8.3%) | 0.100 |
| Renal dysfunction | 1 (1.1%) | 2 (2.1%) | 1.000 |
| Cognitive dysfunction | 0 (0.0%) | 1 (1.0%) | 1.000 |
| Ileus | 0 (0.0%) | 1 (1.0%) | 1.000 |
| Ischemic enteritis | 0 (0.0%) | 1 (1.0%) | 1.000 |
| Thrombectomy | 1 (1.1%) | 0 (0.0%) | 0.497 |
| In-hospital death | 1 (1.1%) | 0 (0.0%) | 0.479 |
| Postoperative intubation time (hr) | 2.6 ± 2.8 | 17.4 ± 5.1 | < 0.001 |
| ICU stay (days) | 2.1 ± 0.3 | 2.4 ± 0.8 | < 0.001 |
| Postoperative hospital stay (days) | 16.4 ± 5.2 | 20.2 ± 12.5 | 0.017 |
| Total expense in ICU (dollars) | 1,036 ± 307 | 1,565 ± 1,072 | <0.001 |
| First day expense in ICU (dollars) | 637 ± 37 | 641 ± 44 | 0.012 |
| Last day expanse in ICU (dollars) | 352 ± 183 | 422 ± 213 | 0.002 |
Data were expressed as mean ± standard deviation or as number (%). Abbreviations:ACT activated clotting time; ICU intensive care unit.
Baseline demographic and clinical characteristics of patients who underwent abdominal aortic replacement surgery and were extubated on the day of surgery in the operating room (Group A1) or in the ICU (Group A2)
| Group A1 (n = 34) | Group A2 (n = 61) | ||
|---|---|---|---|
| Age (years) | 69 ± 8 | 69 ± 10 | 0.686 |
| Height (cm) | 164.4 ± 6.1 | 164.4 ± 8.6 | 0.993 |
| Weight (kg) | 61.1 ± 8.6 | 59.8 ± 8.9 | 0.510 |
| Female | 0 (0.0%) | 11 (18.0%) | 0.007 |
| Medical history | |||
| Hypertension | 21 (61.8%) | 42 (68.9%) | 0.484 |
| Diabetes mellitus | 5 (14.7%) | 15 (24.6%) | 0.257 |
| Hyperlipidemia | 7 (20.6%) | 14 (23.0%) | 0.790 |
| Chronic obstructive pulmonary disease | 4 (11.8%) | 3 (4.9%) | 0.245 |
| Interstitial pneumonia | 0 (0.0%) | 1 (1.6%) | 1.000 |
| Asthma | 1 (2.9%) | 3 (4.9%) | 1.000 |
| Angina pectoris | 5 (14.7%) | 4 (6.6%) | 0.274 |
| Previous cardiac surgery | 3 (8.8%) | 11(18.0%) | 0.366 |
| Coronary intervention | 8 (23.5%) | 7 (11.5%) | 0.123 |
| Smoking | 15 (44.1%) | 26 (42.6%) | 0.888 |
| Arrhythmia | 5 (14.7%) | 1 (1.6%) | 0.021 |
| Cardiac disease | 1 (2.9%) | 1 (1.6%) | 1.000 |
| Hemodialysis | 0 (0.0%) | 2 (3.3%) | 0.536 |
| Medication | |||
| Calcium channel blocking agent | 18 (52.9%) | 27 (44.3%) | 0.417 |
| β receptor blocker | 10 (29.4%) | 7(11.5%) | 0.029 |
| ARB/ACEI | 13 (38.2%) | 30 (49.2%) | 0.304 |
| Statin | 7 (20.6%) | 13 (21.3%) | 0.934 |
Data were expressed as mean ± standard deviation or as number (%).
Abbreviations:ARB angiotensin II receptor blocker; ACEI angiotensin-converting enzyme inhibitor; ICU intensive care unit.
Postoperative outcomes in patients who underwent abdominal aortic replacement surgery and were extubated on the day of surgery in the operating room (Group A1) or in the ICU (Group A2)
| Group A1 (n = 34) | Group A2 (n = 61) | ||
|---|---|---|---|
| Operating time (min) | 267 ± 56 | 274 ± 63 | 0.592 |
| Anesthetic time (min) | 374 ± 53 | 380 ± 66 | 0.696 |
| Intraoperative parameters | |||
| Infusion volume (ml) | 4512 ± 1229 | 3978 ± 1023 | 0.041 |
| Transfusion | 16 (47.1%) | 22 (36.1%) | 0.294 |
| Urinary volume (ml) | 839 ± 642 | 668 ± 502 | 0.319 |
| Amount of bleeding (ml) | 699 ± 481 | 718 ± 450 | 0.698 |
| Mesenteric traction syndrome | 2 (5.9%) | 5 (8.2%) | 1.000 |
| Final ACT | 147 ± 18 | 148 ± 18 | 0.908 |
| Epidural anesthesia | 17 (50.0%) | 16 (26.2%) | 0.020 |
| ICU-related parameters | |||
| Albumin volume (ml) | 129 ± 380 | 203 ± 379 | 0.147 |
| Transfusion | 1 (2.9%) | 4 (6.6%) | 0.652 |
| Postoperative complications | |||
| Respiratory disorders | 0 (0.0%) | 2 (3.3%) | 0.536 |
| Renal dysfunction | 1 (2.9%) | 0 (0.0%) | 0.358 |
| Thrombectomy | 1 (2.9%) | 0 (0.0%) | 0.358 |
| In-hospital death | 0 (0.0%) | 1 (1.6%) | 1.000 |
| Postoperative intubation time (hr) | 0 | 4.0 ± 2.6 | NA |
| ICU stay (days) | 2.0 ± 0.2 | 2.1 ± 0.3 | 0.647 |
| Postoperative hospital stay (days) | 15.8 ± 5.1 | 16.7 ± 5.3 | 0.496 |
| Total expense in ICU (dollars) | 1,003 ± 272 | 1,054 ± 326 | 0.813 |
| First day expense in ICU (dollars) | 645 ± 52 | 633 ± 23 | 0.700 |
| Last day expense in ICU (dollars) | 337 ± 166 | 361 ± 193 | 0.563 |
Data were expressed as mean ± standard deviation or as number (%).
Abbreviations:ACT activated clotting time; ICU intensive care unit.